Shenzhen Hepalink Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Shenzhen Hepalink Pharmaceutical Group has a total shareholder equity of CN¥12.2B and total debt of CN¥4.5B, which brings its debt-to-equity ratio to 36.8%. Its total assets and total liabilities are CN¥18.6B and CN¥6.4B respectively.
Key information
36.8%
Debt to equity ratio
CN¥4.49b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥2.67b |
| Equity | CN¥12.21b |
| Total liabilities | CN¥6.36b |
| Total assets | CN¥18.57b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SHEZ.F's short term assets (CN¥10.7B) exceed its short term liabilities (CN¥4.5B).
Long Term Liabilities: SHEZ.F's short term assets (CN¥10.7B) exceed its long term liabilities (CN¥1.9B).
Debt to Equity History and Analysis
Debt Level: SHEZ.F's net debt to equity ratio (14.9%) is considered satisfactory.
Reducing Debt: SHEZ.F's debt to equity ratio has reduced from 88.5% to 36.8% over the past 5 years.
Debt Coverage: SHEZ.F's debt is well covered by operating cash flow (49.8%).
Interest Coverage: Insufficient data to determine if SHEZ.F's interest payments on its debt are well covered by EBIT.